However, the differences in the plasma GP29 and GP34 glycan levels were only observed in the control participants, and the GP16 and GP23 glycan levels in the plasma only differed in the patients with PTSD (Table 4 and Table 5). This evidence concerns the gene TNFSF4 and post-traumatic stress disorder.